During the past decade, Hospital das Clinicas - FMUSP_X; Neurologia conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Hospital das Clinicas - FMUSP_X; Neurologia" are "Alzheimer Disease" (2 trials), "Muscular Atrophy, Spinal" (2 trials) and "Progressive Multiple Sclerosis (PMS)" (1 trials). Many other conditions were trialed in "Hospital das Clinicas - FMUSP_X; Neurologia" in a lesser frequency.

Most popular intervention types in "Hospital das Clinicas - FMUSP_X; Neurologia" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (2 trials), "Risdiplam" (2 trials), "Ocrelizumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital das Clinicas - FMUSP_X; Neurologia" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Hospital das Clinicas - FMUSP_X; Neurologia". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital das Clinicas - FMUSP_X; Neurologia, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital das Clinicas - FMUSP_X; Neurologia, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".